Search

everythinglearnresearchcommunity

for

Search:↓

Ber‐EP4 marks cells related to the secondary hair germ in hair follicles.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Trichofolliculoma is a unique benign tumor mainly affecting middle-aged adults' faces, often misdiagnosed without histopathology.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

CD10 and CD34 levels change during hair development and different hair growth stages, which could be important for hair regeneration treatments.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

Higher levels of MiR-92a-1-5p and miR-328-3p found in female hair loss patients.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Early recognition and evaluation of nevus sebaceus are crucial to detect and manage potential cancerous changes.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

A person had two different benign skin tumors, a trichoadenoma and melanocytic naevi, at the same time but in different places on the face.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Targeting colon cancer stem cells might lead to better treatment results.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

An 8-year-old girl had a rare, benign skin tumor on her forehead.

Cystic panfolliculoma is a rare, harmless tumor that can be confused with other skin tumors.

Panfolliculoma is a rare, non-cancerous growth related to hair follicles.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

Hair repigmentation can indicate malignancy and should be investigated.

Men with baldness due to androgenetic alopecia still have hair stem cells, but lack specific cells needed for hair growth.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.